{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:28:29Z","timestamp":1793831309202,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ23H310005"],"award-info":[{"award-number":["LQ23H310005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LMS25H020006"],"award-info":[{"award-number":["LMS25H020006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY995"],"award-info":[{"award-number":["2025KY995"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202380"],"award-info":[{"award-number":["82202380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.178006","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T06:27:51Z","timestamp":1753511271000},"page":"178006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Novel GSDMD inhibitor GI-Y1 attenuates sepsis-induced myocardial dysfunction by targeting Gasdermin D and inhibiting Gasdermin D-mediated pyroptosis"],"prefix":"10.1016","volume":"1003","author":[{"given":"Si","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wante","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozhi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5124-5882","authenticated-orcid":false,"given":"Shanshan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178006_bib1","first-page":"183","article-title":"Engineered neutrophil apoptotic bodies ameliorate myocardial infarction by promoting macrophage efferocytosis and inflammation resolution","volume":"9","author":"Bao","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ejphar.2025.178006_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.178006_bib3","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","article-title":"Gasdermin D in pyroptosis","volume":"11","author":"Burdette","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2025.178006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155105","article-title":"Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD","volume":"121","author":"Dai","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2025.178006_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.7191","article-title":"Emodin alleviates LPS-induced myocardial injury through inhibition of NLRP3 inflammasome activation","author":"Dai","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2025.178006_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.779432","article-title":"GSDMD mediates LPS-induced septic myocardial dysfunction by regulating ROS-dependent NLRP3 inflammasome activation","volume":"9","author":"Dai","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.178006_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2025.178006_bib8","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178006_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.688140","article-title":"DL-3-n-Butylphthalide attenuates myocardial hypertrophy by targeting gasdermin D and inhibiting gasdermin D mediated inflammation","volume":"12","author":"Han","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178006_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2025.178006_bib11","article-title":"Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: a comparative retrospective study","volume":"97","author":"Jeong","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.ejphar.2025.178006_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151268","article-title":"Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction","volume":"132","author":"Jiang","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178006_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi9284","article-title":"NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation","volume":"10","author":"Jiang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2025.178006_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178006_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","article-title":"Gasdermins: effectors of pyroptosis","volume":"27","author":"Kovacs","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178006_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101215","article-title":"STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3","volume":"24","author":"Li","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2025.178006_bib17","article-title":"CD47- and integrin alpha4\/beta1-Comodified-Macrophage-Membrane-Coated nanoparticles enable delivery of colchicine to Atherosclerotic Plaque","volume":"11","author":"Li","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejphar.2025.178006_bib18","article-title":"The regulation and modification of GSDMD signaling in diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178006_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178006_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.immuni.2019.04.017","article-title":"Crystal structures of the full-length murine and human gasdermin D reveal mechanisms of autoinhibition, lipid binding, and oligomerization","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2025.178006_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/bph.70040","article-title":"GI-Y2, a novel gasdermin D inhibitor, attenuates sepsis-induced myocardial dysfunction by inhibiting gasdermin D-mediated pyroptosis in macrophages","author":"Mei","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178006_bib22","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1084\/jem.20190545","article-title":"Gasdermins and their role in immunity and inflammation","volume":"216","author":"Orning","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178006_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat2738","article-title":"Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis","volume":"3","author":"Rathkey","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ejphar.2025.178006_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-023-01068-9","article-title":"Regulated cell death pathways in cardiomyopathy","author":"Sheng","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2025.178006_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2025.178006_bib26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178006_bib27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2025.178006_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar6689","article-title":"Gasdermin D plays a vital role in the generation of neutrophil extracellular traps","volume":"3","author":"Sollberger","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ejphar.2025.178006_bib29","first-page":"459","article-title":"Macrophage membrane-mediated targeted drug delivery for treatment of spinal cord injury regardless of the macrophage polarization states","volume":"16","author":"Tang","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2025.178006_bib30","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/CCM.0b013e318174db05","article-title":"Actual incidence of global left ventricular hypokinesia in adult septic shock","volume":"36","author":"Vieillard-Baron","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.178006_bib31","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ad4aaa","article-title":"Macrophage membrane-coated nanoparticles for the treatment of infectious diseases","volume":"19","author":"Wang","year":"2024","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.ejphar.2025.178006_bib32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","article-title":"Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis","volume":"180","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178006_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174644","article-title":"Syringaresinol attenuates sepsis-induced cardiac dysfunction by inhibiting inflammation and pyroptosis in mice","volume":"913","author":"Wei","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178006_bib34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00392-013-0584-z","article-title":"Severity of cardiac impairment in the early stage of community-acquired sepsis determines worse prognosis","volume":"102","author":"Wilhelm","year":"2013","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178006_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejphar.2025.178006_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113199","article-title":"Irisin attenuates sepsis-induced cardiac dysfunction by attenuating inflammation-induced pyroptosis through a mitochondrial ubiquitin ligase-dependent mechanism","volume":"152","author":"Xiong","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178006_bib37","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","article-title":"Concepts of artificial intelligence for computer-assisted drug discovery","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2025.178006_bib38","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.apsb.2022.02.023","article-title":"Cell membrane coated-nanoparticles for cancer immunotherapy","volume":"12","author":"Zeng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2025.178006_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jconrel.2020.01.047","article-title":"Macrophage-based nanotherapeutic strategies in ulcerative colitis","volume":"320","author":"Zhang","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2025.178006_bib40","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejphar.2025.178006_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107544","article-title":"IL-30 protects against sepsis-induced myocardial dysfunction by inhibiting pro-inflammatory macrophage polarization and pyroptosis","volume":"26","author":"Zhao","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ejphar.2025.178006_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00395-023-01010-4","article-title":"GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia\/reperfusion injury by blocking pyroptotic pore formation","volume":"118","author":"Zhong","year":"2023","journal-title":"Basic Res. Cardiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925007605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925007605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:03:34Z","timestamp":1772784214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925007605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":42,"alternative-id":["S0014299925007605"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178006","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel GSDMD inhibitor GI-Y1 attenuates sepsis-induced myocardial dysfunction by targeting Gasdermin D and inhibiting Gasdermin D-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178006"}}